# Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition

> **NCT03284593** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 199 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** intensive chemotherapy
- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT03284593
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-12
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03284593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03284593, "Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03284593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*